Ausgabe 10/2010
Inhalt (9 Artikel)
Reflections on Attribution and Decisions in Pharmacovigilance
Ola Caster, I. Ralph Edwards
How to Apply the Human Factor to Periodic Safety Update Reports
Brian David Edwards, Giovanni Furlan
Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder
Gary Stiefel, Frank M.C. Besag
Proton Pump Inhibitors and Fracture Risk
Michael Bodmer, Christian Meier, Marius E. Kraenzlin, Christoph R. Meier
Nature, Occurrence and Consequences of Medication-Related Adverse Events During Hospitalization
Lilian H.F. Hoonhout, Martine C. de Bruijne, Cordula Wagner, Henk Asscheman, Gerrit van der Wal, Maurits W. van Tulder
Mapping the Safety Profile of Biologicals
Thijs J. Giezen, Aukje K. Mantel-Teeuwisse, Ronald H.B. Meyboom, Sabine M.J.M. Straus, Hubert G.M. Leufkens, Toine C.G. Egberts
Drug-Drug Interactions in Cardiac and Cardiothoracic Intensive Care Units
Pamela L. Smithburger, Sandra L. Kane-Gill, Amy L. Seybert
Pharmacovigilance Activities in Nepal
Subish Palaian, Mohamed Izham Mohamed Ibrahim, Pranaya Mishra, Kadir Alam, Pathiyil Ravi Shankar, Bhupendra Bahadur Thapa